Results 1 to 10 of about 1,114,407 (265)

Immunotargeting of Integrin αβ for Single-Photon Emission Computed Tomography and Near-Infrared Fluorescence Imaging in a Pancreatic Cancer Model

Molecular Imaging, 2016
To explore suitable imaging probes for early and specific detection of pancreatic cancer, we demonstrated that α 6 β 4 integrin is a good target and employed single-photon emission computed tomography (SPECT) or near-infrared (NIR) imaging for ...
Winn Aung MBBS, PhD, Atsushi B. Tsuji PhD, Hitomi Sudo PhD, Aya Sugyo M.Ed, Takako Furukawa PhD, Yoshinori Ukai PhD, Yoshikazu Kurosawa PhD, Tsuneo Saga MD, PhD   +7 more
doaj   +1 more source

Author Correction: Development and Evaluation of 18F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC

Scientific Reports, 2021
Yan Song, Zunyu Xiao, Kai Wang, Xiance Wang, Chongqing Zhang, Fang Fang, Xilin Sun, Baozhong Shen   +7 more
doaj   +1 more source

Molecular Imaging

Analytical Sciences, 2021
openaire   +3 more sources

Prospects of molecular imaging

Cancer Imaging, 2011
Modern radiotherapy techniques heavily rely on high-quality medical imaging. Increased accuracy to deliver the dose to tumours while sparing normal tissues demands more precise delineation of the tumours. When considering to deliver a boost to more aggressive parts of tumours, intratumoral heterogeneity needs to be assessed accurately.
openaire   +2 more sources

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia

Cancer Imaging
Introduction Cancer cachexia is a multifactorial syndrome characterised by involuntary weight loss and muscle wasting, commonly seen in patients with advanced malignancies.
G. J. O’Keefe, C. Senko, S. T. Lee, S. J. Gong, S. Pillai, R. Fogliaro, T. Chen, G. Ninatti, K. Pathmaraj, Z. Cao, I. Burvenich, L. Osellame, N. Hoogenraad, A. M. Scott   +13 more
doaj   +1 more source

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

Cancer Immunology, Immunotherapy
Tissue factor (TF) is a cell surface protein that plays a role in blood clotting but is also commonly expressed in many cancers. Recent research implicated TF in cancer proliferation, metastasis, angiogenesis, and immune escape.
Seiichiro Takao, Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L. Choyke, Hisataka Kobayashi   +10 more
doaj   +1 more source

Chemistry of Molecular Imaging [PDF]

Accounts of Chemical Research, 2009
Thomas J, Meade, Silvio, Aime
openaire   +2 more sources

Therapy-induced modulation of tumor vasculature and oxygenation in a murine glioblastoma model quantified by deep learning-based feature extraction

Scientific Reports
Glioblastoma presents characteristically with an exuberant, poorly functional vasculature that causes malperfusion, hypoxia and necrosis. Despite limited clinical efficacy, anti-angiogenesis resulting in vascular normalization remains a promising ...
Nadine Bauer, Daniel Beckmann, Dirk Reinhardt, Nicole Frost, Stefanie Bobe, Raghu Erapaneedi, Benjamin Risse, Friedemann Kiefer   +7 more
doaj   +1 more source

One section, two worlds: single-cell integration of MALDI-MSI and spatial transcriptomics on the same single tissue section

Scientific Reports
Understanding tissue complexity requires spatially resolved multi-omics data at single-cell resolution. Here, we present a workflow integrating high-resolution matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) with Xenium ...
Tim F. E. Hendriks, Gert B. Eijkel, Theodoros Visvikis, Benjamin Balluff, Ron M. A. Heeren, Eva Cuypers   +5 more
doaj   +1 more source

Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP

Translational Psychiatry
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is a robust, rapid-acting antidepressant whose molecular effects have not been fully elucidated. Phosphodiesterase-4 (PDE4), which terminates cyclic adenosine monophosphate (cAMP) activity, may
Paul A. Parcon, Amanda Bardhoshi, Amanda Olsen-Dufour, Raven Cureton, Susovan Jana, Cheryl L. Morse, Ioline D. Henter, Julia Totis, Adrian E. Jenson, Matilah T. Pamie-George, Jeih-San Liow, Sami S. Zoghbi, Shawn Wu, Victor W. Pike, Robert B. Innis   +14 more
doaj   +1 more source